SEC Form 4 · accession 0001396677-17-000019
NUTRACEUTICAL INTERNATIONAL CORP · NUTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley E Soper
Officer — SVP & Chief Legal Officer
Period of report
Apr 6, 2017
Accepted (ET)
Apr 10, 2017 · 10:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001050007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 6, 2017 | A | 65 | $30.875 | A | 5,174 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase reported in this Form 4 was effected pursuant to an enrollment plan under the issuer's Stock Purchase Plan for Employees, Stakeholders and Shareholders adopted by the reporting person on May 13, 2016.